Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
GSK-4024484 by GSK for Malaria: Likelihood of Approval
GSK-4024484 is under clinical development by GSK and currently in Phase I for Malaria. According to GlobalData, Phase I drugs...